Identification of drug-specific public TCR driving severe cutaneous adverse reactionsRen‐You Pan(Chang Gung Memorial Hospital), Wen‐Hung Chung(Hebei Medical University)Nature CommunicationsAugust 8, 201910.1038/s41467-019-11396-2Cited by 121SaveCiteExport RISWatch citationsRelated PapersAn Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice|Frontiers in Pharmacology|2022|44Immune checkpoint inhibitor-induced severe epidermal necrolysis mediated by macrophage-derived CXCL10 and abated by TNF blockade|Nature Communications|2024|23